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Escherichia coli sequence types 131 (ST131) and 1193 are multidrug-resistant
extraintestinal pathogens that have recently spread epidemically among humans and are
occasionally isolated from companion animals. This study characterized a nationwide
collection of fluoroquinolone-resistant (FQR) E. coli isolates from extraintestinal infections
in Australian cats and dogs. For this, 59 cat and dog FQR clinical E. coli isolates
(representing 6.9% of an 855-isolate collection) underwent PCR-based phylotyping and
whole-genome sequencing (WGS). Isolates from commensal-associated phylogenetic
groups A (14/59, 24%) and B1 (18/59, 31%) were dominant, with ST224 (10/59,
17%), and ST744 (8/59, 14%) predominating. Less prevalent were phylogenetic groups
D (12/59, 20%), with ST38 (8/59, 14%) predominating, and virulence-associated
phylogenetic group B2 (7/59, 12%), with ST131 predominating (6/7, 86%) and no
ST1193 isolates identified. In a WGS-based comparison of 20 cat and dog-source
ST131 isolates with 188 reference human and animal ST131 isolates, the cat and
dog-source isolates were phylogenetically diverse. Although cat and dog-source
ST131 isolates exhibited some minor sub-clustering, most were closely related to
human-source ST131 strains. Furthermore, the prevalence of ST131 as a cause of
FQR infections in Australian companion animals was relatively constant between this
study and the 5-year-earlier study of Platell et al. (2010) (9/125 isolates, 7.2%). Thus,
although the high degree of clonal commonality among FQR clinical isolates from
humans vs. companion animals suggests the possibility of bi-directional between-
species transmission, the much higher reported prevalence of ST131 and ST1193
among FQR clinical isolates from humans as compared to companion animals suggests
that companion animals are spillover hosts rather than being a primary reservoir for
these lineages.
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INTRODUCTION
Extraintestinal pathogenic E. coli (ExPEC) strains have an
enhanced ability to traverse from their usual gut environment
to normally sterile extraintestinal body sites and cause disease
(Johnson et al., 2016). Before the 2000s most ExPEC strains
were susceptible to critically important antimicrobials (CIAs)
such as fluoroquinolones (FQs) and extended-spectrum
cephalosporins (ESCs) (Pitout, 2012), however, multidrug
resistance is increasingly common globally (Nicolas-Chanoine
et al., 2014). Resistance to FQs, ESCs, and carbapenems is
of special concern due these drugs’ critical role in humans
for treating life-threatening infections such as urosepsis
(Matsumura et al., 2017).
Emerging FQ resistance is due mostly to the expansion
and spread of sequence type (ST) ST131, a clonal lineage
from E. coli phylogenetic group B2, first identified in 2008 on
three continents (Coque et al., 2008; Lau et al., 2008; Nicolas-
Chanoine et al., 2008). Genomic epidemiological analysis using
Bayesian estimation predicts that FQ-resistance-conferring point
mutations in chromosomal genes gyrA and parC occurred
around 1987 in North America, coinciding with the first clinical
use of FQs in the USA in 1986 (Ben Zakour et al., 2016; Stoesser
et al., 2016). Most FQ-resistant (FQR) ST131 strains derive from
a single sub-ST clade, designated clade C (Petty et al., 2014),
or H30R (Price et al., 2013) Clade C/H30R in turn exhibits a
prominent sub-lineage, referred to as clade C2 (Petty et al., 2014)
or H30Rx (Johnson et al., 2016), members of which typically
exhibit ESC resistance, mediated by the CTX-M-15 extended-
spectrum β-lactamase (ESBL). ST131 (and, specifically, clade
C/H30R) has become the most prevalent CIA-resistant human
ExPEC lineage globally (Dautzenberg et al., 2016), causing
millions of antimicrobial-resistant (AMR) infections annually
(Pitout and DeVinney, 2017).
Recently, ST1193, another lineage of FQR group B2 E. coli,
has also emerged as an important multidrug-resistant (MDR)
human pathogen (Johnson et al., 2019; Tchesnokova et al., 2019).
ST1193 was identified first in Australia as an emerging FQR
clonal group (Platell et al., 2012), and has now been reported
worldwide, including in Asia (Kim et al., 2017; Wu et al., 2017;
Xia et al., 2017), North America (Tchesnokova et al., 2019),
and Europe (Jorgensen et al., 2017; Valenza et al., 2019). In a
recent multi-center study (United States, 2016–2017), ST1193
represented one-quarter of all FQR human clinical urine isolates
(Tchesnokova et al., 2019).
The cause of such widespread dissemination of AMR ExPEC
lineages is unclear. Host-to-host transmission, including between
animals and humans, likely contributes, in view of documented
colonization of multiple members of the same household with
the same ExPEC strain (Johnson et al., 2016) and the occurrence
of (human-associated) pandemic lineages such as ST131 and
ST1193 in dogs and cats (Johnson et al., 2009c; Pomba et al.,
2009; Platell et al., 2012). The first reported case of an E. coli
ST131 infection in an animal involved a dog with a UTI
in Portugal. Within-household ST131 transmission between
humans and pets (particularly dogs and cats) has also been
documented. Additionally, in the first description of FQR ST1193
as a potential pandemic clone, two isolates were from dogs.
As such, companion animals may be an important reservoir of
these resistant clonal lineages for acquisition by humans, and
humans may be a reservoir of pathogens for their pets (Timofte
et al., 2014). Notably, however, in the few relevant clinical
and/or ecological studies (apart from the initial report involving
ST1193), both ST131 and ST1193 have been relatively rare among
companion animal ExPEC isolates (Platell et al., 2012; Pitout
and DeVinney, 2017), consistent with the human reservoir being
primary. Additionally, both clonal lineages have been reported
recently in fecal samples from wild scavenging birds (Mukerji
et al., 2019; Zurfluh et al., 2019), which suggests another potential
zoonotic reservoir and/or transmission pathway.
Relevant to the human-companion animal interface, previous
studies have documented the emergence of FQR ST131 in
Australian companion animals (Platell et al., 2010, 2011a;
Guo et al., 2015), as both an extraintestinal pathogen and a
gastrointestinal colonizer of hospitalized dogs. Whereas Platell
et al. and Guo et al. investigated companion animal-source FQR
E. coli from only one region in Australia, Saputra et al. (2017)
later surveyed companion animal-source E. coli on an Australia-
wide level; they found that 9.3% of 514 dog isolates and 5% of
341 cat isolates were FQR. Based on these findings, the present
study aimed to determine the prevalence of ST131 and ST1193
among both FQR (both ST131 and ST1193) and FQ-susceptible
(FQS) (ST131 only) members of this Australia-wide E. coli isolate
collection. An additional aim was to compare any identified
companion animal ST131 isolates with members of a multi-
national collection of human and animal ST131 isolates using
whole-genome sequencing (WGS).
MATERIALS AND METHODS
Study Isolates
This study utilized three different sources of isolates. First,
855 clinical E. coli isolates from dogs and cats (January 2013–
January 2014), accompanied by their antimicrobial susceptibility
data, were obtained from the above-mentioned nation-wide
survey of antimicrobial resistance in bacterial pathogens from
Australian animals (Saputra et al., 2017). The isolates had been
collected from 22 government, private, and university veterinary
diagnostic laboratories between January 2013 and January 2014,
accompanied by a brief clinical history and laboratory submission
report, without client details. In all cases, the referring diagnostic
microbiologist considered the isolate significant. Of the isolates,
59 (6.9%) were FQR (48 dog, 11 cat) and 796 (93%) were FQS:
445 dog, 351 cat) (Table 1). Isolates were classified as multidrug-
resistant (MDR) if they showed non-susceptibility to at least one
antimicrobial agent in three or more antimicrobial classes. WGS
was done on these 59 FQR cat and dog-source E. coli isolates as
described in section “WGS of the 59 Cat and Dog-Source FQR
E. coli Isolates” below.
Second, we established an Australian cat and dog-source
ST131 collection (n = 20). This collection included 11 ST131
isolates [six FQR (4 dog, 2 cat), five FQS (all dog)] identified here
within the above-mentioned nation-wide collection of Saputra
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TABLE 1 | Isolates used in this study.
Study Year Country FQ status No. isolates No. of these ST131 Total no. ST131 isolates
Present Study Jan 2013–Jan 2014 Australia FQR 59 6 11
FQS 796 5
Platell et al., 2010 2007–2009 Australia FQR 9 9 9
Ben Zakour et al., 2016 1967–2011 Various FQR 62 62 184
FQS 38 38
Unknown 84 84
Reference Strains 2005–2008 United States, United Kingdom FQR 3 3 4
Unknown Japan Unknown 1 1
et al. (2017). It also included nine FQR ST131 isolates (2007–
2009; 8 dog, 1 cat) from a previous study of ST131 prevalence
among human and companion animal FQR E. coli from eastern
Australia (Platell et al., 2010, 2011a). A more detailed WGS and
phylogenetic analysis were done on these 20 Australian cat and
dog-source ST131 isolates, as described in section “WGS of the
20 Australian Cat and Dog-Source ST131 Isolates” below.
Third, the above 20 Australian cat and dog-source ST131
genomes were placed into a broader context by comparing
them with 188 published diverse-source ST131 genomes (Ben
Zakour et al., 2016), including the complete genomes of four
established ST131 reference strains: EC958 (Totsika et al., 2011)
(GenBank: HG941718), SE15 (GenBank: AP009378), JJ1886
(GenBank: CP006784), and JJ1887 (GenBank: CP014316). The
final multi-national dataset included the genomes of 208 ST131
isolates, as collected between 1967 and 2014 in nine countries:
The United States (n = 83); The United Kingdom (n = 27);
Australia (n = 44); Spain (n = 20); Canada (n = 19); New Zealand
(n = 6); India (n = 5); Portugal (n = 1); Japan (n = 1); and Korea
(n = 1). In addition to the 20 Australian cat and dog-source ST131
study isolates, the multi-national ST131 genome dataset included
isolates from cats (n = 3), dogs (n = 3), avian species (n = 7),
a dolphin (n = 1), and a primate (n = 1). Single-locus variants
of ST131 were counted as ST131. Isolate names and available
metadata are summarized in Supplementary Table S1.
PCR-Based Phylogenetic Grouping and
ST131 Status
E. coli phylogenetic group was determined for the present 855
clinical E. coli study isolates from Australian dogs and cats (59
FQR, 796 FQS) by using the revised Clermont multiplex PCR
assay (Clermont et al., 2013). This identified 594 isolates (7 FQR,
587 FQS) as belonging to group B2. The B2 isolates were then
screened for ST131-specific single-nucleotide polymorphisms
(SNPs) in mdh and gyrB (Johnson et al., 2009b), which
identified six (86% of 7) FQR and five (0.9% of 587) FQS B2
isolates as ST131.
WGS of the 59 Cat and Dog-Source FQR
E. coli Isolates
DNA extraction and WGS was done on the present 59 cat and
dog-source FQR E. coli study isolates (48 dog, 11 cat) using the
Illumina Next Seq platform as described (Abraham et al., 2018).
The resulting FASTQ files were trimmed using CLC Genomics
Workbench (QIAGEN Version 12), with a quality limit of 0.01,
and reads with an ambiguous base were trimmed (ambiguous
limit = 1). De novo assembly for each isolate was also performed
using the CLC Genomics Workbench, using the default settings
(Rahimi et al., 2018). WGS analysis was undertaken using web-
based tools available at the Centre for Genome Epidemiology
(CGE) and custom BLAST databases implemented in the CLC
Genomics Workbench (see Supplementary Material B).
Isolates were classified provisionally as ExPEC if they
contained ≥ 2 of 5 hallmark ExPEC-associated VGs, i.e., papA
and/or papC, sfa/focDE, afa/draBC, kpsM II, and iutA (Johnson
et al., 2003), and as UPEC if they contained ≥ 3 of 4 hallmark
UPEC-associated VGs (Virulance Genes), i.e., chuA, fyuA, vat,
and yfcV (Spurbeck et al., 2012). Additionally, isolates classified
as ST131 were analyzed to determine the presence of 12
prototypic ST131-associated VGs, i.e., iha, fimH, sat, fyuA/irp2,
iutA/iucD, kpsM II, usp, traT, ompT, and malX (Riley, 2014).
ST131 Maximum-Likelihood Analysis and
Phylogenetic Tree Construction
WGS of the 20 Australian Cat and Dog-Source ST131
Isolates
For WGS of the 20 Australian cat and dog-source ST131
isolates, genomic DNA was extracted from overnight LB broth
cultures using MoBio UltraClean Microbial DNA isolation kit
(QIAGEN), per the manufacturer’s instructions. Sequencing was
done using the Illumina NextSeq 500 platform (San Diego, CA,
United States) at the Australian Centre for Ecogenomics1. For
this, NextSeq DNA libraries were prepared using the Nextera
XT Library Preparation Kit (Illumina) with the Nextera XT
Index Kit (Illumina) and were sequenced using a NextSeq 500
2 × 150 bp High-Output v2 kit (Illumina). WGS generated a
median of 3.65 million reads per sample (IQR: 2.87–4.30 million
reads; range: 2.33–5.11 million reads) (Supplementary Table S2).
Sequence read data have been submitted to the National Center
for Biotechnology Information (NCBI) Sequence Read Archive
(SRA) under BioProject PRJNA627752.
Multi-Continental ST131 Sequence Data
The publicly available sequence read data, which had
passed previously defined quality controls (Ben Zakour
1http://ecogenomic.org/services
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et al., 2016), were downloaded from the NCBI SRA
using the “prefetch” and “FASTQ-dump” tools within
the SRA Toolkit v2.9.0-mac642 (Supplementary Table
S3). The methods used for quality control, MLST
and de novo assembly for this dataset are available in
Supplementary Material B.
High-Resolution Phylogenetic Reconstruction of
ST131
Strain EC958 was used as the template reference genome
for generating a SNP-based phylogeny for 208 multi-national
ST131 isolate genomes, including the 20 newly sequenced
cat and dog-source ST131 isolates from Australia and the
188 published diverse-source genomes (Price et al., 2013;
Petty et al., 2014) (Supplementary Table S4). For this, the
coordinates of prophage and genomic island elements in the
complete chromosome of EC958 were masked (Supplementary
Table S5) using the bedtools (Quinlan and Hall, 2010)
v2.27.1 “maskfasta” function. The trimmed paired-end reads
from the 208 ST131 isolates were mapped onto the EC958-
masked chromosome using the Bowtie 2 v2.3.4.2 read aligner
within the Nesoni v0.132 pipeline under default settings3.
Pseudo-genomes were created for each strain by integrating
strain-specific SNPs into the backbone of EC958, which
were then aligned to generate a multiple-genome alignment
(Petty et al., 2014).
All polymorphic substitution sites were concatenated into a
multi-FASTA alignment that was filtered for recombination by
using the Gubbins algorithm (default settings, “raxml mode”
with the General Time Reversible (GTR) GAMMA correction).
Removal of putatively recombined regions left 7,527 total non-
recombinant core-genome SNPs. The recombination-filtered
SNP alignment was imported into jModelTest v2.1.10 (Guindon
and Gascuel, 2003; Darriba et al., 2012) and 12 candidate
models were tested from three substitution schemes, with
the base tree for likelihood calculations optimized for ML
and parameters “ + F,” “ + I,” “ + G (nCat = 4).” The
GTR nucleotide substitution model with GAMMA distribution
was determined as the best-fit evolutionary model based on
the lowest Akaike and Bayesian Information Criterion (AIC
and BIC) scores.
The evolutionary history was inferred by importing this
alignment into RAxML (Stamatakis, 2014) v8.2.10 (GTR-
GAMMA correction) and using the ML method thorough
optimization of the 20 distinct randomized Maximum Parsimony
trees, before adding 1,000 bootstrap replicates. FigTree visualized
the ML phylogenetic tree outputs and exported the trees in
NEXUS format. NEXUS trees were visualized in EvolView
v2 (Zhang et al., 2012; He et al., 2016) for final output
generation. The recombination-filtered SNP alignment also was
converted into a pairwise SNP distance matrix using snp-
dists v0.24.
2http://ncbi.github.io/sra-tools
3https://github.com/Victorian-Bioinformatics-Consortium/nesoni
4https://github.com/tseemann/snp-dists
RESULTS
Phylogenetic Grouping of FQR Isolates
The present study’s 59 Australian cat and dog-source FQR E. coli
isolates were distributed broadly by phylogenetic group (in order
of descending prevalence) as follows: B1 (31%), A (24%), D
(20%), B2 (12%), F (10%), and C (3%). Nearly all isolates qualified
as MDR (56/59, 95%), and MDR isolates exhibited a similar
phylogenetic group distribution as did the total population of 59
isolates (not shown).
Whole Genome Sequenced-Based
Analyses
STs, ARGs, and VGs identified for each isolate by in silico analysis
are shown in Supplementary Table S6.
In silico MLST
According to in silico MLST the 59 Australian cat and dog-
source FQR isolates represented 18 STs, including one novel ST
(ST8242; phylogroup C). Ten STs accounted for ≥ 2 isolates
each, the other eight (including ST8242) for a single isolate
each. The five most prevalent STs – ST38 (eight isolates), ST131
[six isolates (these strains had already been identified as ST131
by SNP PCR)], ST224 (10 isolates), ST744 (eight isolates), and
ST2179 (six isolates) – accounted for 64% of the 59 FQR isolates
(Figure 1). Six STs occurred among both cat and dog-source
isolates (ST38, ST131, ST224, ST354, ST744, and ST2179). None
of the isolates represented other major STs associated with FQR
human UTI isolates, e.g., ST1193.
The six phylogroup F isolates from STs 354 (5 isolates) and 648
(1 isolate) were characterized previously (Vangchhia et al., 2016).
Consequently, they did not undergo further genomic analysis
here and are not included in the following sections, which are
limited to the remaining 53 sequenced FQR isolates.
ARGs
The 53 further-analyzed FQR isolates contained two PMQR
genes, including aac(6’)-lb-cr (25%) and qnrS1 (2%). The most
common CTX-M type ESBL genes were blaCTX−M−15 (25%)
and blaCTX−M−14 (6%). The AmpC β-lactamase gene blaCMY−2
was identified in 12 isolates (23%) and blaOXA−1 in 13 isolates
(25%). The ESBL genes blaCTX−M−15, blaCTX−M−14 were both
identified in isolates belonging to ST38 and ST131. Isolates
containing blaCTX−M−15 were also assigned to ST405, ST410, and
ST627, while blaCTX−M−14-containing isolates also belonged to
ST224. The AmpC β-lactamase gene blaCMY−2 was identified in
ST38, ST224, ST617, ST744, and ST2179, whereas blaOXA−1 was
identified in ST38, ST131, ST405, ST410, and ST617.
VGs
The 53 further-analyzed FQR isolates contained 160 distinct
VGs (representing 51 operons). Of the 160 VGs, 16 (10%)
occurred in all 53 isolates; these included ompA (outer
membrane protein), entABCDEFS (enterobactin siderophore
system), fepACDG (ferric enterobactin uptake), and ecpABCDE
(E. coli common pilus).
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FIGURE 1 | Sequence type frequency among 59 fluoroquinolone-resistant cat and dog clinical Escherichia coli isolates that underwent whole genome sequencing.
The number of VGs per isolate differed by phylogroup,
and within a given phylogroup differed by ST. By phylogroup,
isolates from groups B2 and D contained the most VGs per
isolate (medians, 80 and 88, respectively), followed by those
from phylogroups B1 (median 61.5), C (median 58), and A
(median 43.5) (Supplementary Table S6). By ST, isolates from
ST131 (phylogroup B2) and ST38 (phylogroup D) contained
the most VGs per isolate (medians 81 and 92.5, respectively),
whereas those from ST744 (phylogroup A) and ST224 (group B1)
contained the fewest (medians 39 and 54.5, respectively).
Nine of the 53 FQR isolates qualified molecularly as ExPEC
(but not UPEC), one as UPEC (but not ExPEC), and one as
both ExPEC and UPEC, giving 10 total ExPEC isolates (19%)
and two UPEC isolates (4%). Of the 10 ExPEC isolates, nine
(90%) belonged to phylogroups B2 (n = 3; all from ST131) or D
(n = 6; 5 from ST38, 1 from ST349); the sole exception was from
phylogroup A (ST744).
Serotypes, fimH Alleles, ARGs, and VGs in the FQR
vs. FQS ST131 Isolates From Cats and Dogs in
Australia
Regarding O:H serotypes and fimH alleles, the six FQR ST131
isolates exhibited two predicted combinations, O16:H5 fimH41
(n = 1) and O25:H4 fimH30 (n = 5; representing the C/H30R
subclone). Regarding resistance characteristics, all six isolates
were MDR and possessed at least two β-lactamase genes,
including blaCTX−M−15 (three of five C/H30R isolates) and
blaCTX−M−14 and blaCTX−M−27 (one isolate each). Four isolates
were MDR; two of these contained, respectively, aac(6’)-Ib-cr or
qnrB4. The five FQS ST131 strains also exhibited two predicted
serotype-fimH allele combinations, O16:H5 fimH41 (n = 2) and
O25:H4 fimH22 (n = 3). Four isolates were MDR, and one each
contained aac(6’)-Ib-cr or qnrB4.
Regarding virulence genotypes of FQR vs. FQS companion
animal-source ST131 isolates, the six dog or cat-source FQR
ST131 isolates each contained 72–94 putative VGs (median 81
VGs). Although none of the six had all 12 prototypic ST131-
associated VGs, i.e., iha, fimH, sat, fyuA/irp2, iutA/iucD, kpsM
II, usp, traT, ompT, and malX (Riley, 2014), three contained
all 12 of these genes except iutA and ompT, while the other
three additionally lacked only usp. Three of the six FQR ST131
isolates qualified as ExPEC but none as UPEC. By comparison,
the five FQS dog-source ST131 isolates each contained 71-100
VGs (median 79 VGs). Like the FQ ST131 strains, none contained
all 12 prototypic ST131-associated VGs, however, one isolate
contained all of these except iutA and ompT, whereas the rest
contained ≤ 9 of the 12 genes each. One dog-source FQS
ST131 isolate qualified as both ExPEC and UPEC, one as ExPEC
only, and one as UPEC only. Thus, FQR and FQS companion
animal ST131 isolates from Australia possess similar virulence
characteristics.
Phylogenetic Relationships Among 208
Multi-National ST131 Isolates, Including 20 From
Australian Cats and Dogs and 188 From Diverse Host
Species in Other Locales
Mapping of Illumina reads from the 208 diverse-source ST131
isolates to the EC958 ST131 reference chromosome identified
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7,527 non-recombinant core-genome SNPs (Figure 2). After
masking of SNPs within the 577,661 bp of identified prophage
and genomic island sequence (11.3% of the EC958 genome) a
ML phylogeny was inferred. The phylogeny had strong bootstrap
support for its topology, which matched that of previous reports
(Price et al., 2013; Ben Zakour et al., 2016), including resolution
of the three major ST131 clades (A, B, and C, corresponding
to the H41, H22 and H30 fimH fimbrial types). Most of the 20
Australian cat and dog-source ST131 isolates fell within Clade
C/H30 (13/20, 65%; 8/13, 62% in C1/H30R1 and 5/13, 38% in
C2/H30Rx), followed distantly by Clades A/H41 (4/20, 20%) and
B/H22 (3/20, 15%) (Figure 2).
Notwithstanding the absence of an obvious animal-only
clade, seven of the 20 Australian cat and dog-source ST131
isolates clustered closely within three sub-clades (Figure 2). (i)
C1/H30R1 strains MS10902 and MS10903, which differed by only
six SNPs, were dog-source urine isolates from Victoria (Platell
et al., 2010). (ii) C2/H30Rx strains N13/4/101 and N13/1/351,
which differed by only 20 SNPs, were dog urine isolates from
New South Wales that clustered with strain N13/4/38 (dog
trachea biopsy isolate, also from New South Wales) in another
sub-clade (Saputra et al., 2017). These differed by only 42–
72 SNPs from two human isolates collected in 2011 in the
United Kingdom (strains S118EC and S119EC). Strain JJ2008,
a cat isolate collected in the United States, formed an outgroup
to this mixed human/animal sub-clade (Figure 2). (iii) The
remaining two isolates, H22/B strains N13/1/75 and S13/1/53
(dog-source urine and ear swab isolates from New South
Wales and South Australia, respectively) (Saputra et al., 2017),
formed a sub-clade and differed from one another by only 96
SNPs (Figure 2).
DISCUSSION
This study, which sought to characterize genetically a nationwide
collection of clinical FQR E. coli isolates from extraintestinal
infections in Australian dogs and cats (January 2013–January
2014) – including a WGS-based phylogenetic comparison
across host species and geographical regions – led to four
main conclusions. First, most (58%) FQR dog and cat isolates
represented commensal phylogenetic groups A (24%), B1 (31%),
and C (3%), rather than the group B2-derived pandemic lineages
(ST131 and ST1193) that predominate among human FQR
isolates. Second, the prevalence of ST131 as a cause of FQR
E. coli infections in Australian companion animals was similarly
low here among comparatively recent isolates (January 2013–
January 2014) (6/59, 10%) as that noted previously by Platell et al.
among historical isolates (2007–2009) (9/125, 7.2%), suggesting
stability over time. Third, in a SNP-based phylogeny, the ST131
isolates from companion animals and humans were intermingled
throughout the tree, rather than forming host-specific clades.
This, together with the comparatively low prevalence of ST131
among isolates from companion animals, supports the hypothesis
that companion animals in Australia are spillover hosts for
ST131. Fourth, the absence of ST1193 among the present
companion animal-source FQR E. coli isolates and its rarity in
FIGURE 2 | Core-genome single nucleotide polymorphisms (SNPs) phylogeny
of 208 Escherichia coli ST131 isolates from humans, cats, dogs, and other
animals. The Maximum Likelihood tree was built using 7,527 non-recombinant
core-genome single nucleotide polymorphisms (SNPs), as called by mapping
sequencing reads to the chromosome of EC958 (GenBank: HG941718.1)
with masked genomic islands and prophage regions. Colored groupings
represent three labeled clades. H41/A (red), H22/B (orange), and C1/C2/H30
(green). Branch lengths are drawn to scale and represent the number of
nucleotide substitutions per site (scalebar) or number of SNPs (key). Pink
labels represent isolates collected from animals. Boldface pink labels with an
asterisk represent the 20 cat and dog-source ST131 isolates sequenced as
part of this study (11 from the Saputra et al. (2017) study, and nine [indicated
by the MS prefix] from the Platell et al. (2010) study).
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other companion animal-source isolate collections suggests that
the same spillover hypothesis likely applies also to this clonal
group, which is emerging among humans but not in animals.
Regarding our first main conclusion, according to most studies
ExPEC derive mainly from phylogroups B2, D, and F, and
non-pathogenic commensal E. coli from phylogroups A and
B1 (Johnson and Stell, 2000; Vangchhia et al., 2016). Today,
resistance to FQs and ESCs among human-source clinical E. coli
is due mainly to the group B2-derived lineages ST131 and
ST1193, most members of which qualify as ExPEC (Johnson
et al., 2019; Tchesnokova et al., 2019). By contrast, prior to
these two clonal groups’ recent emergence and expansion, most
FQR human-source clinical isolates belonged to groups A and
B1, and typically contained fewer VGs than did FQS isolates
(Clermont et al., 2000).
The present study confirms that this historic pattern of
phylogroup distribution persists among recent dog and cat-
source FQR clinical E. coli isolates from Australia. Whilst
the overall prevalence of FQ resistance in the Australia-wide
collection of companion animal E. coli is low (< 10%) by
international standards (Saputra et al., 2017), the FQR isolates
belonged predominantly to groups A and B1 and possessed
fewer VGs than group B2 and D isolates, with only seven
of 53 (13%) FQR non-ST131 isolates qualifying molecularly as
ExPEC. These findings echo a comparable study conducted over
10 years ago on E. coli isolates from North American dogs with
UTI, in which FQR differed significantly in VG content (fewer)
and phylogenetic background (mostly non-group B2) from FQS
isolates (more VGs, mostly B2) (Johnson et al., 2009a).
Regarding our second main conclusion, comparison of the
present findings with those of the regionally based study of Platell
et al. (2010) confirmed that the prevalence of ST131 as a cause of
FQR clinical infections in Australian companion animals did not
increase significantly over the 5 year between-study interval. Two
recent studies documented ST131 as a cause of extraintestinal
infections in companion animals in Europe, but identified
different proportions of C1/H30R1 vs. C2/H30Rx among cat and
dog-source isolates (Belas et al., 2018; Melo et al., 2019). However,
neither included a detailed genomic comparison with human
ST131 isolates. Specifically, among urine E. coli isolates from cats
and dogs in Portugal (1999–2015), 15% (25/172) of group B2
isolates were ST131, of which seven (28%) represented C/H30.
Three (43%) of the C/H30 isolates represented the C2/H30Rx
subclade, and two of these possessed blaCTX−M−15 (Belas et al.,
2018). Likewise, among more recent ESC-resistant E. coli isolates
from cats and dogs in France (2010–16), most ST131 isolates
represented C/H30 (50/56, 89%), 32 (64%) of which represented
the C2/H30Rx subclade, and several possessed blaCTX−M−27
(Melo et al., 2019). By contrast, 36% (4/11) of the present cat
and dog ST131 isolates (one of which was identified as carrying
the blaCTX−M−27 gene), and only 11% (1/9) of those studied by
Platell et al. (2010), represented the C2/H30Rx subclade. Taken
together, these four studies suggest that the C2/H30Rx clade is
becoming more common as a cause of extraintestinal infection
in companion animals. A larger multicenter study involving
genomic comparison of more recent companion animal ST131
isolates is needed to confirm this hypothesis.
Regarding human-companion animal ST131 clonal
commonality, our comparison of 20 Australian cat and
dog-source ST131 genomes with 173 human-source ST131
genomes (Ben Zakour et al., 2016) confirmed that the animal-
source isolates were widely distributed throughout the ST131
phylogeny, in many cases placed closely to human ST131 strains.
The absence of a separate clade containing only companion
animal ST131 strains suggests a spillover model for ST131
occurrence in companion animals, as hypothesized previously
(Bourne et al., 2019). Indeed, some animal ST131 strains shared
very high identity with human strains. For example, MS10899, an
Australian cat urine isolate (2007–2009), differed from P189EC, a
Spanish human fecal isolate (2011), by only 66 non-recombinant
core-genome SNPs (Figure 2). Although we cannot exclude
that an individual from Spain came into contact with a cat in
Australia in 2005, a more plausible explanation is the existence
of an as-yet undefined reservoir or transmission network of
circulating ST131 strains that links Australia and Spain (and,
likely, much of the rest of the world).
Regarding our third main conclusion, human-animal clonal
commonality implies interspecies transmission potential (of
indeterminate direction), whereas the comparative prevalence
of ST131 among human vs. animal clinical isolates implicates
humans rather than companion animals as the main reservoir.
Combined with the fact that the relative prevalence of ST131
among clinical isolates from dogs in Australia was fairly stable
between 2007 and 2009 (Platell et al., 2010) and 2013 (this
study), this adds further support for the hypothesis that ST131
causes infections predominantly in humans, with cats and dogs
representing occasional spillover hosts (Melo et al., 2019). It
is plausible, however, that pets may carry significant numbers
of ST131 strains in the gut and could facilitate interspecies
transfer to humans, who may simply be more susceptible than
pets to developing extraintestinal infection due to ST131. By
contrast, pets may be predisposed to developing infection due
to other E. coli STs such as ST372, which is comparatively
rarer among humans (LeCuyer et al., 2018; Kidsley et al., 2020;
Valat et al., 2020).
Despite the overall genetic diversity of the Australian cat and
dog-source ST131 isolates, some sub-clustering was apparent
within the reference strain ST131 phylogeny. Based on the
geographical, temporal, and host species metadata and minimal
SNP diversity, it is likely that a single epidemiological source (per
cluster) gave rise to each of the three clusters of closely related
companion animal isolates within ST131 clades B, C1/H30R1,
and C2/H30Rx. Given the distribution of the 34 animal ST131
isolates within the SNP-based phylogeny and the spillover
hypothesis, further work will be required to characterize the
reservoirs and transmission pathways that facilitate the spread of
ST131 beyond the human population (Platell et al., 2011b).
Regarding our fourth main conclusion, ST1193 – another
emerging clonal lineage of FQR E. coli within phylogroup B2
(Johnson et al., 2019; Tchesnokova et al., 2019; Valenza et al.,
2019) — accounted for none of the 53 present FQR cat and
dog isolates, despite having accounted for two FQR dog clinical
isolates from Australia in the earlier Platell et al. study (Platell
et al., 2012). To our knowledge only two other studies have
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recovered ST1193 from companion animals. Maeyama et al.
(2018) identified five ESC resistant ST1193 isolates among 381
clinical E. coli isolates from companion animals in Japan in
2016 (Maeyama et al., 2018); while Zhang et al. (2018) identified
one (n = 24) CTX-M-positive ST1193 of clinical origin in
Canada (Zhang et al., 2018). ST1193’s rarity of isolation from
companion animals suggests that ST1193, like ST131, is likely
is predominantly a human-source clone, for which dogs are
mainly spillover hosts. Regarding possible alternate transmission
pathways for ST1193, in a recent Australian study a high
proportion of silver gulls carried ESC-resistant and FQR E. coli
in their feces. Whilst the most commonly identified ST was
ST131 (17%), a substantial proportion of isolates represented
ST1193 (6%), and these were closely related to human isolates
(Mukerji et al., 2019).
This study has relevant limitations. First, selection bias may
have influenced the observed distribution of FQR STs, since
the study isolates came from veterinary diagnostic laboratories,
which preferentially receive specimens from complicated cases
and hosts with prior antimicrobial therapy (unpublished data).
Second, detailed clinical data were lacking. Third, the clinical
impact of the observed in vitro and genotypically predicted
antimicrobial resistance is unknown. The study also has
strengths: these include the large sample size (n = 855, making
it the largest such study to date), the "snapshot" 1-year study
period, the broad geographical sampling across Australia, and
the genomic comparison with a large multi-national collection of
(predominantly human-source) reference ST131 genomes.
CONCLUSION
In conclusion, we found that despite ST131 being the most
prevalent ExPEC strain reported globally among humans, it
occurred only at comparatively low frequency among FQR and
FQS E. coli clinical isolates from Australian cats and dogs over
a 1-year period in 2013–2014 (10%), with little change since
2007–2009 (7.2%). Phylogenomic comparisons of ST131 isolates
from humans, cats, and dogs in Australia showed that despite
some sub-clustering, the animal isolates were widely distributed
throughout the ST131 phylogeny, often closely resembling
human isolates. By contrast with ST131, ST1193, although
identified first as an emerging clonal group among Australian
FQR human and animal-source E. coli from 2007–2009 (Platell
et al., 2012), was absent from the present FQR dog and cat
isolate collection.
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